DR NEERGAARDS VEJ 5F, HOERSHOLM, G7
To Present Three-Year Clinical Efficacy Data for Personalized Cancer Vaccine EVX-01 at the ESMO Congress 2026
Presents New Preclinical Data for Cytomegalovirus Vaccine Program EVX-V1
Material disclosure
Receives Prix Galien UK Award for Best Digital Health Solution
Presents New Preclinical Data for EVX-04, an Off-the-Shelf Therapeutic Vaccine for Acute Myeloid Leukemia
To present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
Announces Business Update and First Quarter 2026 Financial Results
To Announce Business Update and First Quarter 2026 Financial Results on May 7, 2026
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities of Certain Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities of Certain Foreign Private Issuers
No filings found
Initial Statement of Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Correspondence
Submission Upload